Stock Update (NASDAQ:CELG): Celgene Corporation Elects Mark Alles and Jacqualyn Fouse PhD to its Board of Directors

[Business Wire] – Celgene Corporation today announced the election of Mark Alles and Jacqualyn Fouse PhD to its Board of Directors. Read more on this. Celgene Corporation (CELG) , valued at $79.66B, opened this morning at $100.31. During the trading session, CELG traded between $99.25 to $102.15 and has traded between $92.98 and $140.72 over the past 12 months. Celgene (CELG) shares are currently priced at 17.11x this year’s forecasted earnings, which makes them relatively expensive compared to the industry ’s -3.21x earnings multiple for the same period. Consensus earnings for the current quarter by the 19 sell-side analysts covering the stock is an estimate of $1.28 per share, which would be $0.21 better than the year-ago quarter and a $0.01 sequential decrease. Investors should also note that the full-year EPS estimate of $5.72 is a $1.01 improvement when compared to the previous year’s annual results. The quarterly earnings estimate is predicated on a consensus revenue forecast of $2.60 Billion. If reported, that would be a 25.00% increase over the year-ago quarter. In terms of ratings, Credit Suisse Initiated CELG at Outperform (Jan 20, 2016). Previously, Standpoint Research Initiated CELG at to Buy. The average price target for CELG shares by the analysts covering the stock is $139.29, which is 38.86% above where the stock opened this morning. See more in (NASDAQ:CELG) Similar Articles: Stock Update (NASDAQ:CELG): Celgene Reports Fourth Quarter and Full Year 2015 Operating and Financial Results Market Update (NASDAQ:CELG): Organizational Changes Strengthen Leadership Team and Position Celgene for Long-Term Growth Company Update (NASDAQ:CELG): Celgene Reports Third Quarter 2015 Operating and Financial Results